Sai Parenteral's (NSE:SAIPARENT) Preferred Dividends: ₹0 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SAIPARENT Sai Parenteral's Ltd NSE:SAIPARENT
14 GF Score
Price ₹569.70
! 7 Warning Signs
View Full Analysis

What is Sai Parenteral's Preferred Dividends?

Sai Parenteral's NSE:SAIPARENT +5.28% 14 Preferred Dividends is ₹0 Mil as of Sep. 2025. GuruFocus rates NSE:SAIPARENT with a GF Score™ of 14/100. The stock has 7 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Sai Parenteral's's preferred dividends for the six months ended in Sep. 2025 was ₹0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Sep. 2025 was ₹0 Mil.

Sai Parenteral's  (NSE:SAIPARENT) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Parenteral's Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Sai Parenteral's's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Parenteral's Preferred Dividends Chart

Sai Parenteral's Annual Data
Trend Mar23 Mar24 Mar25
Preferred Dividends
0.00 0.00 0.00

Sai Parenteral's Semi-Annual Data
Mar23 Mar24 Mar25 Sep25
Preferred Dividends 0.00 0.00 0.00 0.00
NSE:SAIPARENT
14GF Score
Sai Parenteral's Ltd NSE:SAIPARENT
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sai Parenteral's Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of ₹0 Mil mean?
Sai Parenteral's (NSE:SAIPARENT) has a Preferred Dividends of ₹0 Mil as of Sep. 2025. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Sai Parenteral's and its competitors.
Is Sai Parenteral's' Preferred Dividends too high?
Sai Parenteral's' current Preferred Dividends is ₹0 Mil. Overall, Sai Parenteral's has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Sai Parenteral's' Preferred Dividends compare to LLY and JNJ?
Sai Parenteral's' Preferred Dividends of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Drug Manufacturers company?
A good Preferred Dividends depends on the Drug Manufacturers industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Sai Parenteral's and its competitors. Sai Parenteral's's current Preferred Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Parenteral's stock overvalued right now?
Sai Parenteral's (NSE:SAIPARENT) has a current Preferred Dividends of ₹0 Mil. The current Preferred Dividends is ₹0 Mil. Sai Parenteral's' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Sai Parenteral's (NSE:SAIPARENT), the current Preferred Dividends is ₹0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sai Parenteral's Business Description

Other Exchanges 544742:India
Address Plot No 39, 5th floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, K.V.Rangareddy, Seri Lingampally, Hyderabad, TG, IND, 500032
Sai Parenteral's Ltd is a diversified pharmaceutical formulations company. Its business is organised in two verticals: (i) Branded Generic Formulations: Through the branded generics portfolio, it serves the domestic market with formulations across multiple therapeutic areas. and (ii) Contract Development and Manufacturing Organisation (CDMO): It provides CDMO services to pharmaceutical companies, supporting activities from product development to commercial manufacturing. Its product portfolio includes cardiovascular care, neuropsychiatry, anti-diabetic therapy, respiratory health, antibiotics, gastroenterology, vitamins, etc. The majority of the company's revenue is derived from the Branded Generic Formulations business.
14GF Score

Get the complete analysis for NSE:SAIPARENT

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹569.70
Price